85 reports

  • Market definition
  • Cancer pain

You can easily book an appointment with one online.

  • Blood Disease
  • Chemotherapy
  • Amgen Inc.
  • Helsinn Group
  • Merck & Co., Inc.
  • GLOBAL ORAL CHEMOTHERAPY DRUGS MARKET,
  • GLOBAL ORAL CHEMOTHERAPY DRUGS MARKET,

Powerful suppliers ##.

  • Chemotherapy
  • World
  • Bristol-Myers Squibb Company
  • Celgene Corporation
  • Eli Lilly & Co.
  • 2.7.2 Chemotherapy-Induced Neutropenia

Tanezumab is an analgesic and is one of the two products in the pipeline that is likely to obtain approval over the forecast period and become commercially successful, but it is not an opioid and does not target GPCR.

  • Chemotherapy
  • Amgen Inc.
  • Daiichi Sankyo Company
  • Eli Lilly & Co.
  • Insys Therapeutics, Inc.

Globally, nearly ## in ## people die of cancer.

  • Chemotherapy
  • World
  • B. Braun Melsungen AG
  • Baxter International Inc.
  • Becton Property Group

Common treatments for bone pain include strong analgesics, typically opioids such as morphine, hydromorphone, fentanyl, and oxycodone.

  • Chemotherapy
  • Company
  • Novartis AG
  • Pfizer Inc.
  • Roche Group

There are many small producers whose capacity is below one million yuan.

  • Chemotherapy
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Roche Group
  • MARKET OVERVIEW

The usage of antiemetic drugs to treat postoperative nausea and vomiting (PONV) due to analgesics and anesthesia is fueling the market in recent years.

  • Chemotherapy
  • World
  • GlaxoSmithKline plc
  • Pfizer Inc.
  • Sanofi S.A.

Its broad portfolio of drug products Chapter VII LEUKEMIA TREATMENT DRUGS PRODUCERS DIRECTORY covers anti-cancer, antibiotics, anti-diabetics, gastro-intestinal, CNS, analgesics & antipyretics in form of tablet, capsule, injection as well as API.

  • Chemotherapy
  • China
  • Supply
  • Tianjin Tianyao Pharmaceutical Co., Ltd
  • Zhejiang Expressway Co., Ltd.

The auto exports exceeded over ## million each year.

  • Chemotherapy
  • China
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Roche Group

Acute pain is usually managed with medications such as analgesics and anesthetics.

  • Chemotherapy
  • China
  • Demand
  • Forecast
  • Market Size

It has one research center in Shanghai and one manufacturing plant in Jiangsu province.

  • Chemotherapy
  • Demand
  • Bayer Schering Pharmaceutical Co., Ltd
  • Changchun ChangSheng Gene Pharmaceutical Co., Ltd.
  • Shenyang Sunshine Pharmaceutical Co., Ltd.

The primary objective was to evaluate analgesic efficacy of a single dose of intravenous tanezumab ##mg.

  • Chemotherapy
  • United States
  • Amgen Inc.
  • BeyondSpring Pharmaceuticals Inc.
  • Helsinn Group

You can easily book an appointment with one online.

  • Chemotherapy
  • GlaxoSmithKline plc
  • Helsinn Group
  • Heron Therapeutics, Inc.
  • Merck & Co., Inc.

Prostate cancer

4385 5000 3900

PROSTATE CANCER DRUGS CAN FOLLOW TWO ROUTES TO GAIN APPROVAL Analgesic intake should be assessed using validated scales.

  • Chemotherapy
  • Europe
  • European Union
  • North America
  • United States
  • KCP-400 - DRUG PROFILE

EpiCept NP-## is a topical analgesic cream containing two FDA-approved drugs, amitriptyline and ketamine, in development for the relief of pain from various peripheral neuropathies.

  • Chemotherapy
  • Neurological Disorder
  • Pharmaceutical
  • United States
  • Product Initiative

Trials conducted by companies in Phase IV, Phase III, Phase II and Phase I stand at ##, ##, ## and ## respectively.

  • Chemotherapy
  • Hospital
  • Therapy
  • World
  • Product Initiative
  • SMALL MOLECULES TO MODULATE S1PR FOR CENTRAL NERVOUS SYSTEM AND TOXICOLOGY - DRUG PROFILE
  • SMALL MOLECULES TO BLOCK NAV 1.8 FOR CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY - DRUG PROFILE

EpiCept NP-## is a topical analgesic cream containing two FDA-approved drugs, amitriptyline and ketamine, in development for the relief of pain from various peripheral neuropathies.

  • Chemotherapy
  • Drug Development
  • United States
  • Company
  • Product Initiative

PLOS ONE, ##(##), E## < DOI> ##. ##/ JOURNAL.

  • Chemotherapy
  • Health Care Provider
  • Hormone
  • Therapy
  • United States

The effective date will be July ##, 2019.

  • Chemotherapy
  • China
  • United States
  • Product Initiative
  • Helsinn Group

## ## ## ## China ## ## ## ## ## ## ## Brazil ## ## ## ## ## ## ## Mexico ## ## ## ## ## ## ## Turkey ## ## ## ## ## ## ## Russia ## ## ## ## ## ## ## Indonesia Source: GlobalData' s Pharma Intelligence Center Clinical Trials Database

  • Chemotherapy
  • Clinical Trial
  • Neurology
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • Cancer
  • Chemotherapy
  • Clinical Trial
  • United States
  • World

Of ## subjects analyzed for NRG-## expression, two patients were NRG-## positive, one of whom, a patient with squamous non-small cell lung cancer, achieved a partial response.

  • Chemotherapy
  • Lung Cancer
  • United States
  • World
  • Product Initiative

The prominent features of this report are - ##.

  • Chemotherapy
  • Clinical Trial
  • Neurology
  • World
  • Product Initiative
  • Clinical Trial profile. 121 Trial Title
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Chemotherapy
  • Clinical Trial
  • Hospital
  • World
  • Product Initiative

The company' s pipeline products comprise therapies such as SP-##-##, SP-##-##, SP-##-## and SP-##-##.

  • Cancer
  • Chemotherapy
  • United States
  • World
  • Product Initiative

## ## ## ## ## ## ## ## ## ## ## ## ## ## Pfizer Inc ## ## ## ## ## Neurotune AG ## ## ## ## ## NEMA Research Inc ## ## ## ## ## Kancera AB ## ## ## ## ## Helsinn Holding SA Source: GlobalData' s Pharma I

  • Chemotherapy
  • Oncology
  • Therapy
  • World
  • Product Initiative
  • Clinical Trial profile. 111 Trial Title
  • 5. All the trials included are unique trials.

The prominent features of this report are - ##.

  • Chemotherapy
  • Clinical Trial
  • Monoclonal Antibody
  • Respiratory Disease
  • F. Hoffmann-La Roche Ltd.

Trials conducted by companies in Phase III, Phase II and Phase I stand at ##, ## and ## respectively.

  • Chemotherapy
  • Leukemia
  • Therapy
  • World
  • TRACON Pharmaceuticals, Inc.

Patients will be randomized ##:##:## to one of three arms: CABOMETYX and Opdivo; CABOMETYX, Opdivo and Yervoy; or sunitinib.

  • Cancer
  • Chemotherapy
  • United States
  • Product Initiative
  • Exelixis, Inc.
  • CLINICAL TRIAL PROFILE SNAPSHOTS

Hoffmann-La Roche Ltd ## ## ## ## ## ## Eli Lilly and Co ## ## ## ## ## ## E.

  • Chemotherapy
  • Clinical Trial
  • Pharmaceutical
  • World
  • Product Initiative